The 20 Best Neuroblastoma Doctors near New Hyde Park, NY

Vincent Vinciguerra, MD, is Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Board certified in Internal Medicine, Hematology and Medical Oncology, Dr. Vinciguerra specializes in treating gastrointestinal cancers and breast cancer. As an attending physician at the Monter Cancer Center, Dr. Vinciguerra focuses on providing compassionate, personalized, and evidence-based care. He also has devoted his career to Cancer Control and Prevention programs. He is the principal investigator for the National Cancer Institute (NCI) supported National Community Oncology Research Program which offers clinical trials and innovative therapies for cancer patients. Dr. Vinciguerra has published over 100 journal articles on cancer drug trials and treatments related to his national and international collaborations. Dr. Vinciguerra earned his medical degree and trained in internal medicine at the Georgetown University Medical Center. He completed training in Hematology/Oncology at New York Hospital. Dr. Vinciguerra is an active member of the American Society of Hematology, American Society of Clinical Oncology and the American College of Physicians. Dr. Vinciguerra is rated as an Advanced provider by MediFind in the treatment of Neuroblastoma. His top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, Familial Colorectal Cancer, and Colorectal Cancer.

Julie Krystal is a Pediatrics specialist and an Oncologist in New Hyde Park, New York. Dr. Krystal is rated as an Advanced provider by MediFind in the treatment of Neuroblastoma. Her top areas of expertise are Neuroblastoma, Medulloblastoma, Acute Lymphoblastic Leukemia (ALL), Rhabdomyosarcoma, and Bone Marrow Aspiration.

Mark Atlas is a Pediatric Hematologist Oncology provider in Lake Success, New York. Dr. Atlas is rated as an Experienced provider by MediFind in the treatment of Neuroblastoma. His top areas of expertise are Optic Glioma, Glioma, Medulloblastoma, and Acute Lymphoblastic Leukemia (ALL).

Steven R. Savona, MD, is an attending physician based at the Monter Cancer Center where his major clinical interests include blood disorders such as malignant and non-malignant hematology diseases as well as oncology expertise in the areas of diseases of the skin including melanoma, basal cell cancer and squamous cell cancer; he also sees patients with colorectal cancer and pancreas cancer. Dr. Savona maintains an active medical practice focusing on compassionate, personalized, evidence-based multi-disciplinary care. Board certified in Internal Medicine, Medical Oncology, Hematology and Hospice/Palliative medicine, Dr. Savona is an Assistant Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Dr. Savona is an active participant in the Cancer Control Program of the National Cancer Institute sponsored clinical trials based at Northwell. He is an investigator on cancer control studies, studies for the treatment of cancer of the pancreas as well as squamous cancer of the skin. In prior studies, Dr. Savona has addressed issues such as tobacco dependency and smoking cessation, redeveloping life styles and physical activity levels after completion of chemotherapy, the prevention of infections in patients with impaired immunity and prevention of hot flashes in patients on hormonal therapy. Dr. Savona earned his medical degree from Duke University School of Medicine. He completed both his residency in internal medicine and his fellowship in Medical Oncology/Hematology at New York University Medical Center. Dr. Savona is an active member of the American Society of Hematology and the American Society of Clinical Oncology. Dr. Savona is rated as an Experienced provider by MediFind in the treatment of Neuroblastoma. His top areas of expertise are Malignant Peripheral Nerve Sheath Tumor, Bone Tumor, Melanoma, Thrombocytopenia, and Bone Marrow Aspiration.

Louis Kavoussi, MD, MBA, Director of teleintervention at Northwell. He is a world-renowned urologic surgeon who brings more than 30 years of specialized expertise in minimally invasive urological surgery. His area of focus includes treating a wide range of urologic diseases, including kidney obstructions, renal stones and urologic cancer. At the forefront of innovation, Dr. Kavoussi pioneered several new surgical techniques, including the first minimally invasive approaches to kidney surgery for kidney cancer and kidney donation. He was also part of the team that performed the first laparoscopic prostate removal for cancer. In 1999, Dr. Kavoussi received a Smithsonian Computerworld Permanent Collection award for his work in developing telerounding, the starting point of telehealth medicine-to facilitate physician communication with hospitalized patients. Before joining Northwell in 2005 as chair of urology, Dr. Kavoussi completed his medical degree at the State University of New York at Buffalo. He obtained his urologic training at Washington University of St. Louis and, directly following residency, was named chief of urology at the Jewish Hospital of St. Louis. In 1991, he was appointed assistant professor at Harvard School of Medicine and director of endourology at the Brigham and Women's Hospital. In 1993, he joined the faculty of Johns Hopkins University School of Medicine, where he was vice chairman of urology and named a Patrick C. Walsh Distinguished Professor. Dr. Kavoussi values a team approach to care, and often collaborates with other specialists to create personalized and comprehensive treatment plans. His patients appreciate his easygoing personality and thoughtfulness. As the Waldbaum-Gardner Distinguished Professor of Urology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Dr. Kavoussi is passionate about training the next generation of surgeons. He has presented his work and given live surgical demonstrations at conferences around the world and has more than 500 academic publications. Dr. Kavoussi is rated as an Experienced provider by MediFind in the treatment of Neuroblastoma. His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, Nephrectomy, and Reconstructive Urology Surgery.

Brenton Francisco is a Pediatrics specialist and a Pediatric Hematologist Oncology provider in New Hyde Park, New York. Dr. Francisco is rated as an Experienced provider by MediFind in the treatment of Neuroblastoma. His top areas of expertise are Sickle Cell Disease, Hemophilia A, Hemophilic Arthropathy, and Hemoglobin SC Disease.

Arlene Redner is a Pediatric Hematologist Oncology provider in New Hyde Park, New York. Dr. Redner is rated as an Experienced provider by MediFind in the treatment of Neuroblastoma. Her top areas of expertise are Optic Glioma, Acute Lymphoblastic Leukemia (ALL), Classical Hodgkin Lymphoma, and Febrile Neutropenia.

Carolyn Levy is a Pediatric Hematologist Oncology provider in New Hyde Park, New York. Dr. Levy is rated as an Experienced provider by MediFind in the treatment of Neuroblastoma. Her top areas of expertise are Langerhans Cell Histiocytosis, Acute Lymphoblastic Leukemia (ALL), Hemi 3 Syndrome, Cantu Syndrome, and Bone Marrow Aspiration.

Rachel Kessel is a Hematologist and an Oncologist in New Hyde Park, New York. Dr. Kessel is rated as an Experienced provider by MediFind in the treatment of Neuroblastoma. Her top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Congenital Athymia, Sickle Cell Disease, and Acute Megakaryoblastic Leukemia.

Lawrence Wolfe is a Pediatrics specialist and a Pediatric Hematologist Oncology provider in New Hyde Park, New York. Dr. Wolfe is rated as an Experienced provider by MediFind in the treatment of Neuroblastoma. His top areas of expertise are Thalassemia, Beta Thalassemia, Hereditary Spherocytosis, and Hemolytic Anemia.

Banu Aygun is a Pediatric Hematologist Oncology provider in New Hyde Park, New York. Dr. Aygun is rated as an Experienced provider by MediFind in the treatment of Neuroblastoma. Her top areas of expertise are Sickle Cell Disease, Congenital Hemolytic Anemia, Hemolytic Anemia, Hemoglobinopathy, and Splenectomy.

Anshul Vagrecha is a Pediatric Hematologist Oncology provider in New Hyde Park, New York. Dr. Vagrecha is rated as an Experienced provider by MediFind in the treatment of Neuroblastoma. His top areas of expertise are Hemophagocytic Lymphohistiocytosis, Multisystem Inflammatory Syndrome in Children (MIS-C), Sickle Cell Disease, and Febrile Neutropenia.

I am a pediatric hematologist/oncologist who specializes in stem cell transplantation and cellular therapy. I graduated from the Upstate Medical University, completed a residency in pediatrics at the Schneider Children's Hospital, served as Chief Resident of Pediatrics at the Schneider Children's Hospital, and then completed my training with a fellowship in pediatric hematology / oncology at the Children s Hospital of Philadelphia. During my fellowship, I concurrently spent 3 years in the laboratory researching cellular immunotherapy for acute lymphoblastic leukemia, while also pursuing a clinical interest in the late effects of childhood cancer treatment. In 2008 I came to the Cohen Children s Medical Center to found Survivors Facing Forward, a long-term follow-up program to provide care to survivors of childhood cancer and stem cell transplantation. Since 2008, the program has grown to follow nearly 1,000 survivors of childhood cancer and has been a fertile source for clinical research.In 2021 I assumed leadership of the stem cell transplantation and cellular therapy program at Cohen Children's Medical Center, where I am the Transplant Center Medial Director and Marrow Collection Facility Director. Our transplant center participates in national and international cooperative group studies in the use of stem cell transplantation and cellular therapy to treat cancers, bone marrow failure syndromes, immune deficiencies and hemoglobinopathies (sickle cell disease and thalassemia). Notably, we are one of a very limited number of Qualified Treatment Centers (QTC) for Zynteglo , an FDA approved gene therapy for transfusion dependent thalassemia, and are in the process of being named a QTC for gene therapy products recently FDA approved to cure sickle cell disease. Dr. Fish is rated as an Experienced provider by MediFind in the treatment of Neuroblastoma. His top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Graft Versus Host Disease (GvHD), Acquired Amegakaryocytic Thrombocytopenia, Sickle Cell Disease, and Bone Marrow Transplant.

Alexandra Satty is a Pediatric Hematologist Oncology provider in New Hyde Park, New York. Dr. Satty is rated as an Experienced provider by MediFind in the treatment of Neuroblastoma. Her top areas of expertise are Congenital Aplastic Anemia, Fanconi Anemia, Aplastic Anemia, Leukocytosis, and Bone Marrow Transplant.

Brian Kushner is a Hematologist and an Oncologist in New York, New York. Dr. Kushner is rated as an Elite provider by MediFind in the treatment of Neuroblastoma. His top areas of expertise are Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Hereditary Neuroblastoma, and Desmoplastic Small Round Cell Tumor. Dr. Kushner is currently accepting new patients.

Nai-kong Cheung is a Hematologist and an Oncologist in New York, New York. Dr. Cheung is rated as an Elite provider by MediFind in the treatment of Neuroblastoma. His top areas of expertise are Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Desmoplastic Small Round Cell Tumor, and Diffuse Midline Glioma H3 K27M-Mutant. Dr. Cheung is currently accepting new patients.

Ellen Basu is a Hematologist and an Oncologist in New York, New York. Dr. Basu is rated as an Elite provider by MediFind in the treatment of Neuroblastoma. Her top areas of expertise are Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Hereditary Neuroblastoma, and Infantile Neutropenia. Dr. Basu is currently accepting new patients.

Suzanne Wolden is a Pediatric Radiologist in New York, New York. Dr. Wolden is rated as an Elite provider by MediFind in the treatment of Neuroblastoma. Her top areas of expertise are Neuroblastoma, Rhabdomyosarcoma, Embryonal Tumor with Multilayered Rosettes, Adult Soft Tissue Sarcoma, and Orchiectomy. Dr. Wolden is currently accepting new patients.

Kim Kramer is a Hematologist and an Oncologist in New York, New York. Dr. Kramer is rated as an Elite provider by MediFind in the treatment of Neuroblastoma. Her top areas of expertise are Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Diffuse Midline Glioma H3 K27M-Mutant, and Medulloblastoma. Dr. Kramer is currently accepting new patients.

Kai Tsao, MD, MS, is the system chief of solid tumor oncology, medical director of the R.J. Zuckerberg Cancer Center, and medical director of the medical oncology prostate cancer program at the Northwell Cancer Institute. He specializes in cancers of the genitourinary organs and has more than a decade of clinical experience. His research focuses on the development of biomarkers and novel therapies for patients with genitourinary cancers.Dr. Tsao was inspired to become an oncologist after witnessing many close family and friends suffering from cancer. He completed medical school training at SUNY Downstate, an internal medicine residency at Long Island Jewish Medical Center, and a fellowship in hematology and medical oncology at Mount Sinai Hospital. He earned a master's degree in healthcare delivery leadership at Icahn School of Medicine at Mount Sinai and completed Lean Six Sigma training at Johns Hopkins.Prior to joining Northwell, Dr. Tsao served as medical director of the Ruttenberg Treatment Center, medical director of the medical oncology prostate cancer program, and physician leader for internal oncology collaborations at the Mount Sinai Hospital, Tisch Cancer Institute. In these roles, Dr. Tsao and his team built a cancer center that is patient centered, quality driven, scientifically innovative, and provided multi-disciplinary care to patients with cancer.For me, patient care much more than the cancer diagnosis and treatment. It is essential to address the many needs of our cancer patients: emotional well-being, social support, nutrition, physical activity, financial challenges and more. We aim to provide the best support for our patients, one at a time.Dr. Tsao is an accomplished physician-scientist who has authored more than 80 peer-reviewed publications in the field of genitourinary oncology. He serves as associate editor of Genitourinary Oncology, Frontiers in Oncology. His leadership in carrying out complex clinical trials in targeted therapies and immunotherapies positions his patients at the forefront of cutting-edge cancer research and patient-centered care.What I most enjoy every day is seeing patients under our care, despite the devastation of their cancer diagnosis, beating their cancer and living a life that was not considered a possibility years ago. Our mission at Northwell Cancer Institute is to make this a reality for every single patient. Dr. Tsao is rated as an Experienced provider by MediFind in the treatment of Neuroblastoma. His top areas of expertise are Prostate Cancer, Renal Cell Carcinoma (RCC), Clear Cell Sarcoma, Orchiectomy, and Nephrectomy.